If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
New patient-friendly option to be made available for Tev-Tropin JERUSALEM & EWING, N.J.–(HSMN NewsFeed)–Teva Clinical Industries Ltd. (Nasdaq: TEVA ) and its partner, Antares Pharmaceutical, Inc. (NYSE Amex: AIS) today announced the approval of a Supple…
Biopharmaceuticals, Drug Delivery, FDA
Teva Pharmaceutical, Antares Pharma, Tev-Tropin
Posts on ‘June 29th, 2009’
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)
Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Former President, Health Care Services for CVS Caremark Corporation Brings Added Global Supply Chain Experience and Expertise to the Board MORRISTOWN, N.J., June 29 (HSMN NewsFeed) — Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and …
Biopharmaceuticals, Personnel
Watson Pharmaceuticals
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
PRINCETON, N.J., June 29 (HSMN NewsFeed) — DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB ), a late-stage biopharmaceutical company, announced today that investigators at the Fred Hutchinson Cancer Research Center, Seattle, Washingto…
Biopharmaceuticals
DOR BioPharma, orBec , beclomethasone, GI GVHD
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Pharma Officer
Dr. Sherman also elected President of the Drug Information Association (DIA) NORTHBROOK, Ill., June 29 (HSMN NewsFeed) — Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced the appointment of Jeffrey W. Sherman, M….
Biopharmaceuticals, Personnel
Horizon Therapeutics
